Cullinan Therapeutics, Inc. (CGEM) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$14.84
+2.41%
Mkt Cap $912.04M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 May 7, 2026 | $3.67M | — | — | -$0.83 | -$0.75 | +9.29% |
| Q1 2026 Mar 10, 2026 | $5.00M | — | — | -$0.80 | -$0.77 | +3.75% |
| Q4 2025 Nov 6, 2025 | $5.56M | — | — | -$0.95 | -$0.77 | +18.95% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.83 | -$1.07 | -28.92% |
| Q2 2025 May 8, 2025 | — | — | — | -$0.78 | -$0.74 | +5.13% |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.75 | -$0.73 | +2.67% |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.78 | -$0.69 | +11.54% |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.73 | -$0.75 | -2.74% |
| Q2 2024 May 15, 2024 | — | — | — | -$0.90 | -$0.86 | +4.44% |
| Q1 2024 Mar 14, 2024 | — | — | — | -$0.96 | -$0.54 | +43.75% |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.91 | -$0.91 | +0.00% |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.99 | -$0.82 | +17.17% |
| Q2 2023 May 11, 2023 | — | — | — | -$0.84 | -$1.42 | -69.05% |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.65 | -$0.59 | +9.23% |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.97 | -$0.54 | +44.33% |
| Q3 2022 Aug 10, 2022 | $275.00M | — | — | $5.47 | -$2.20 | -140.22% |
| Q2 2022 May 16, 2022 | — | — | — | -$0.61 | -$0.27 | +55.74% |
| Q1 2022 Mar 17, 2022 | — | $37.85M | — | -$0.47 | -$0.74 | -57.45% |
| Q4 2021 Nov 9, 2021 | — | — | — | -$0.42 | -$0.40 | +4.76% |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.42 | -$0.36 | +14.29% |
| Q2 2021 May 14, 2021 | $34.50M | $18.94M | -45.10% | $0.07 | -$0.00 | -102.39% |
| Q1 2021 Mar 30, 2021 | — | — | — | -$0.38 | -$2.86 | -652.63% |
| Q1 2021 Jan 6, 2021 | — | — | — | — | -$0.26 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.45 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.26 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.24 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$6.82 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$5.94 | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$5.94 | — |